#MedTech #Ireland #Waterford #Schivo #Mecaplast

Schivo Acquires Mecaplast SA: A Strategic Move in the Precision Manufacturing Sector

On September 3, 2025, Schivo proudly announced its acquisition of Mecaplast SA, a specialized Swiss firm renowned for its high-precision injection-molded components tailored for medical and life sciences applications. This strategic acquisition not only bolsters Schivo's expertise in advanced materials but also reinforces its commitment to being a reliable partner for complex MedTech solutions.

Founded in 1971, Mecaplast has established a stellar reputation for technical excellence in producing mission-critical components, precision molds, and cleanroom assemblies, serving major OEMs in the MedTech and life sciences sectors. Located in Botterens, Switzerland, their facility boasts over 6,000 square meters of dedicated production area, emphasizing the company’s proficiency in technologies like micro-injection molding and multi-component processes.

The integration of Mecaplast into Schivo is a transformative step. This acquisition significantly enhances Schivo's vertical integration capabilities by adding manufacturing, assembly, and value-added services in metal and ceramics. Furthermore, the establishment of a new European competence center will facilitate the introduction of advanced injection molding technologies across Schivo's operations in the United States and Mexico, thereby improving support for MedTech and life sciences OEMs in pivotal international markets.

Graham Reeves, the CEO of Schivo, expressed his enthusiasm, stating, “Mecaplast AG brings decades of deep expertise in complex plastic, metal, and ceramic injection molding that perfectly aligns with our vision of creating a global multi-capabilities platform for advanced medical and life sciences devices, addressing areas such as robotic surgery, minimally invasive procedures, and analytical instrumentation. Their commitment to innovation further enhances our ability to deliver fully integrated solutions across materials, technologies, and international markets.”

Jean-Marc Jaccottet, CEO and owner of Mecaplast, characterized the acquisition as a natural evolution for the company. He stated, “Our team is excited to continue supporting our long-standing customers while also being agile in addressing the needs of new clients. This partnership accelerates investments and developments, leveraging the combined expertise of both firms to amplify the impact of our Swiss engineering excellence in precision molding and high-level manufacturing.”

As part of Schivo’s global excellence center for precision plastics, metal, and ceramic injection molding, Mecaplast’s facilities will play a central role in enhancing the group's capabilities. Jean-Marc Jaccottet will join Schivo's leadership team as President of Injection Molding Technologies, where he will drive advancements in research and innovation while also promoting the growth of the group’s manufacturing capacities. This strategic positioning is set to establish Schivo as a key player in the high-end injection molding solutions sector.

In conclusion, Schivo’s acquisition of Mecaplast exemplifies a forward-thinking approach to expanding its operational prowess and service offerings in the MedTech and life sciences arenas. The united efforts of both companies are bound to create groundbreaking advancements in the precision engineering sector, catering to a diverse array of medical and technological needs across the globe. Interested stakeholders and media inquiries can reach out to Jonathan Roberge, VP of Corporate Development, at the provided contact details.